If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while sleeping—you’re likely familiar with continuous positive airway pressure ...

The Food and Drug Administration has approved Zepbound, a GLP-1 weight-loss drug from Eli Lilly & Co., for the treatment of moderate to severe sleep apnea certain patients with obesity. Photo courtesy ...

Along with diet and exercise, sleep is the third pillar of health. And frankly, a good night's sleep is often the answer to whatever ails you. But for 30 million people in the United States, sleep ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

Sleep apnea is a common sleep disorder that affects more than 20 percent of people in the United States. It happens when your breathing temporarily stops while you sleep. Depending on the severity of ...

Obstructive sleep apnea affects the quality of life of millions of people, but current solutions are not always well accepted ...

Healio Pulmonology has compiled the top news on obstructive sleep apnea posted in 2025.Readers were most interested in ...

Often brushed off as loud snoring, obstructive sleep apnea is a serious disorder that repeatedly cuts oxygen during sleep, ...

We're all chasing better rest. From herbal teas and nighttime routines to white noise machines and tracking apps, quality sleep is now a key part of the wellness conversation. But for people with ...

More than 12 million Americans suffer with sleep apnea, a potentially serious sleep disorder that causes your breathing to start and stop during rest and can lead to heart disease, stroke and diabetes ...

Sleep apnea will become more common and more severe due to global warming, leading to increased health and economic burdens across the globe, warn Flinders University sleep experts. A new study, ...